✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

CARsgen Therapeutics Holdings Ltd

Common Name
CARsgen Therapeutics Holdings
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
355
Ticker
2171
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Carsgen Therapeutics Holdings Limited is a biopharmaceutical company that focuses on innovative CAR-T (Chimeric Antigen Receptor T-cell) therapies for cancer treatment. The company's primary aim is to...

CARsgen Therapeutics Holdings's Revenues Data

Explore CARsgen Therapeutics Holdings's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
17,949,560a
5,402,091a
0b
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind CARsgen Therapeutics Holdings’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. CARsgen Therapeutics Holdings's Annual Report 2025
b. CARsgen Therapeutics Holdings's Annual Report 2024